APOE and Alzheimer disease: The interaction of APOE-ε4 heterozygosity (APOE-ε2/ε4 or -ε3/ε4) and HSV-1 carriage increases AD risk by approximately 12-fold, whereas the presence of only one factor poses a much lower risk (Khokale et al., 2020).